Clinical Trial

Qingre Huatan Formula for the Prevention of Early Neurological Deterioration in Acute Ischemic Stroke

Study acronym: QUIET
Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
The purpose of this study is to assess the effectiveness and safety of Qingre Huatan formula versus placebo on preventing early neurological deterioration in patients with acute ischemic stroke within 48 hours after onset.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-02-27; most recent amendment 2025-11-24.
Status change: Not Yet Recruiting → Recruiting 2025-09-02
Trial Details
NCT Number NCT06857487
Lead Sponsor Dongzhimen Hospital, Beijing
Conditions Acute Ischemic Stroke
Enrollment 72 participants
Start Date 2025-06-13
Primary Completion 2026-10-24 (estimated)
Study Completion 2026-10-29 (estimated)
Updated on ClinicalTrials.gov 2025-12-01